Zwerling A[au] - Search Results

Year	Number of Results
1994	1
2001	1
2002	1
2004	1
2006	1
2007	1
2008	5
2009	6
2010	2
2011	7
2012	5
2013	5
2014	7
2015	5
2016	5
2017	4
2018	1
2019	5
2020	4
2021	7
2022	5
2023	2

1

Tuberculosis screening costs and cost-effectiveness in high-risk groups: a systematic review.

Alsdurf H, Empringham B, Miller C, Zwerling A. Alsdurf H, et al. Among authors: zwerling a. BMC Infect Dis. 2021 Sep 8;21(1):935. doi: 10.1186/s12879-021-06633-3. BMC Infect Dis. 2021. PMID: 34496804 Free PMC article.

2

How much does TB screening cost? A systematic review of economic evaluations.

Empringham B, Alsdurf H, Miller C, Zwerling A. Empringham B, et al. Among authors: zwerling a. Int J Tuberc Lung Dis. 2022 Jan 1;26(1):38-43. doi: 10.5588/ijtld.21.0257. Int J Tuberc Lung Dis. 2022. PMID: 34969427

3

Understanding spending trends for tuberculosis.

Zwerling A. Zwerling A. Lancet Infect Dis. 2020 Aug;20(8):879-880. doi: 10.1016/S1473-3099(20)30316-9. Epub 2020 Apr 23. Lancet Infect Dis. 2020. PMID: 32334657 Free PMC article. No abstract available.

4

The BCG world atlas: a new, open-access resource for clinicians and researchers.

Zwerling A, Pai M. Zwerling A, et al. Expert Rev Anti Infect Ther. 2011 Aug;9(8):559-61. doi: 10.1586/eri.11.71. Expert Rev Anti Infect Ther. 2011. PMID: 21819321 No abstract available.

5

Obstetric anesthesia: changes and choices.

McCool WF, Packman J, Zwerling A. McCool WF, et al. Among authors: zwerling a. J Midwifery Womens Health. 2004 Nov-Dec;49(6):505-13. doi: 10.1016/j.jmwh.2004.08.028. J Midwifery Womens Health. 2004. PMID: 15544979 Review.

6

Disadvantage and the Experience of Treatment for Multidrug-Resistant Tuberculosis (MDR-TB).

Taylor HA, Dowdy DW, Searle AR, Stennett AL, Dukhanin V, Zwerling AA, Merritt MW. Taylor HA, et al. Among authors: zwerling aa. SSM Qual Res Health. 2022 Dec;2:100042. doi: 10.1016/j.ssmqr.2022.100042. Epub 2022 Jan 28. SSM Qual Res Health. 2022. PMID: 35252955 No abstract available.

7

Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIV.

Bjerrum S, Schiller I, Dendukuri N, Kohli M, Nathavitharana RR, Zwerling AA, Denkinger CM, Steingart KR, Shah M. Bjerrum S, et al. Among authors: zwerling aa. Cochrane Database Syst Rev. 2019 Oct 21;10(10):CD011420. doi: 10.1002/14651858.CD011420.pub3. Cochrane Database Syst Rev. 2019. PMID: 31633805 Free PMC article. Review.

8

Modeling of novel diagnostic strategies for active tuberculosis - a systematic review: current practices and recommendations.

Zwerling A, White RG, Vassall A, Cohen T, Dowdy DW, Houben RM. Zwerling A, et al. PLoS One. 2014 Oct 23;9(10):e110558. doi: 10.1371/journal.pone.0110558. eCollection 2014. PLoS One. 2014. PMID: 25340701 Free PMC article. Review.

9

Economic evaluations of point of care testing strategies for active tuberculosis.

Zwerling A, Dowdy D. Zwerling A, et al. Expert Rev Pharmacoecon Outcomes Res. 2013 Jun;13(3):313-25. doi: 10.1586/erp.13.27. Expert Rev Pharmacoecon Outcomes Res. 2013. PMID: 23763529 Review.

10

Mathematical Modelling and Tuberculosis: Advances in Diagnostics and Novel Therapies.

Zwerling A, Shrestha S, Dowdy DW. Zwerling A, et al. Adv Med. 2015;2015:907267. doi: 10.1155/2015/907267. Epub 2015 Mar 15. Adv Med. 2015. PMID: 26556559 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

77 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Results by year